Eco R1 Capital, LLC Arbutus Biopharma Corp Transaction History

Eco R1 Capital, LLC

  • $2.31 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$1.46 - $4.44 $3.17 Million - $9.65 Million
-2,172,883 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$3.41 - $4.57 $3.78 Million - $5.07 Million
-1,108,619 Reduced 33.78%
2,172,883 $7.78 Million
Q4 2018

Feb 14, 2019
BUY
$3.5 - $9.66 $7.17 Million - $19.8 Million
2,049,702 Added 166.4%
3,281,502 $12.6 Million
Q3 2018

Nov 14, 2018
BUY
$7.85 - $12.35 $9.67 Million - $15.2 Million
1,231,800 New
1,231,800 $11.6 Million

Others Institutions Holding ABUS

# of Institutions
157
Shares Held
99.6M
Call Options Held
2.31M
Put Options Held
525K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $499M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email